Extension of Time to File SOU

KAMYSA

Mylan Pharmaceuticals, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88114338
LAW OFFICE ASSIGNED LAW OFFICE 111
MARK SECTION
MARK KAMYSA (see, http://uspto.report/TM/88114338/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT KAMYSA
OWNER SECTION
NAME Mylan Pharmaceuticals, Inc.
STREET 781 Chestnut Ridge Road
CITY Morgantown
STATE West Virginia
ZIP/POSTAL CODE 26505
COUNTRY United States
EMAIL XXXX
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for the treatment of multiple sclerosis
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 04/23/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /SRP/
SIGNATORY'S NAME Samir Patel
SIGNATORY'S POSITION Associate General Counsel, Global IP
DATE SIGNED 10/18/2019
FILING INFORMATION
SUBMIT DATE Fri Oct 18 15:38:27 EDT 2019
TEAS STAMP USPTO/ESU-XXX.XXX.XXX.XXX
-20191018153827399594-881
14338-6107b48c2b3f7d55f92
fbd97ab8322585883b862ef51
77ac32f8d28675669b8cba0-D
A-38264395-20191018153700
465606



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: KAMYSA (see, http://uspto.report/TM/88114338/mark.png)
SERIAL NUMBER: 88114338

The applicant, Mylan Pharmaceuticals, Inc., having an address of
      781 Chestnut Ridge Road
      Morgantown, West Virginia 26505
      United States
      XXXX (authorized)
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 04/23/2019.

For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of multiple sclerosis

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.



A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /SRP/      Date Signed: 10/18/2019
Signatory's Name: Samir Patel
Signatory's Position: Associate General Counsel, Global IP

RAM Sale Number: 88114338
RAM Accounting Date: 10/18/2019

Serial Number: 88114338
Internet Transmission Date: Fri Oct 18 15:38:27 EDT 2019
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20191018153827
399594-88114338-6107b48c2b3f7d55f92fbd97
ab8322585883b862ef5177ac32f8d28675669b8c
ba0-DA-38264395-20191018153700465606




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed